Identifying Prevalent Cases of Breast Cancer in the French Case-mix Databases

OBJECTIVES Little is known about cancer prevalence due to a lack of systematic recording of cancer patient follow-up data. To estimate the annual hospital prevalence of breast cancer in the general population of the Isère department (1.1 million inhabitants) in the Rhône-Alpes region, the second largest region in France (6 million inhabitants), we used the inpatient case-mix data, available in most European countries, to develop a method of cancer case identification. METHODS A selection process was applied to the acute care hospital datasets among women aged 18 years or older, living in the Isère department and treated for breast cancer between 2004 and 2007. The first step in case selection was based on the national anonymous unique patient identifier. The second step consisted of retrieving all hospital stays for each case. The third step was designed to detect inconsistencies in the coding of the primary localization. An algorithm based on ICD-10 code for the hospital admission diagnosis was used to rule out hospitalizations unrelated to breast cancer. Five possible models for estimating prevalence were created combining selection steps with the admission diagnosis algorithm. RESULTS Hospital prevalence over the four-year period varied from 6073 breast cancer cases for the simplest model (first selection step without the admission diagnosis algorithm) to 4951 when the first selection step was associated with the breast cancer code as admission diagnosis. The model combining the third selection step with a breast cancer-specific admission reason provided 5275 prevalent cases. CONCLUSION The last model seems more appropriate for case-mix-data coding. Selecting admission diagnosis improved specificity. Combining all hospital stays for each patient has improved diagnostic sensitivity.

[1]  C. Colin,et al.  Qualité et utilité d'un identifiant patient anonyme et unique pour le chaînage des séjours hospitaliers dans les bases de données médicoéconomiques françaises , 2007 .

[2]  A. Schott,et al.  Breast cancer incidence using administrative data: correction with sensitivity and specificity. , 2009, Journal of clinical epidemiology.

[3]  Y. Ohno,et al.  Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries. , 2008, Japanese journal of clinical oncology.

[4]  G. Launoy,et al.  Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. , 2008, European journal of cancer.

[5]  A. Mariotto,et al.  Estimating the variance of cancer prevalence from population-based registries , 2006, Statistical methods in medical research.

[6]  Jean Marie Rodrigues,et al.  From DRG databases to an epidemiological observatory for colorectal cancer in a French small area oncology network , 2003, MIE.

[7]  G. Hédelin,et al.  National cancer prevalence estimation in France , 2000, International journal of cancer.

[8]  C. Couchoud,et al.  Intérêt de l'utilisation du PMSI pour l'analyse d'activité cancérologique d'une structure de soins multidisciplinaire : l'expérience de la coordination de cancérologie des Hospices Civils de Lyon , 2002 .

[9]  R. Écochard,et al.  Method of correction to assess the number of hospitalized incident breast cancer cases based on claims databases. , 2002, Journal of clinical epidemiology.

[10]  B. Trétarre,et al.  [Predictive value and sensibility of hospital discharge system (PMSI) compared to cancer registries for thyroïd cancer (1999-2000)]. , 2006, Revue d'epidemiologie et de sante publique.

[11]  R. De Angelis,et al.  Estimating the completeness of prevalence based on cancer registry data. , 1997, Statistics in medicine.

[12]  Paola Pisani,et al.  Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population , 2002, International journal of cancer.

[13]  J. Goodwin,et al.  An approach to identifying incident breast cancer cases using Medicare claims data. , 2000, Journal of clinical epidemiology.

[14]  V. Moreno,et al.  A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  F. Berrino,et al.  Contrasts in cancer prevalence in Connecticut, Iowa, and Utah , 2002, Cancer.

[16]  F A Allaert,et al.  FOIN: a nominative information occultation function. , 1997, Studies in health technology and informatics.

[17]  A. Schott,et al.  Is it possible to estimate the incidence of breast cancer from medico-administrative databases? , 2008, European Journal of Epidemiology.

[18]  C. Quantin,et al.  Estimation de la valeur discriminante des traits d’identification utilisés pour le rapprochement des données d’un patient , 2004 .

[19]  J. Peng,et al.  Evaluation of an algorithm to identify incident breast cancer cases using DRGs data , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[20]  Calculating the prevalence of cancer. , 1992, Statistics in medicine.

[21]  R. De Angelis,et al.  Measuring cancer prevalence in Europe: the EUROPREVAL project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.